New research by the research team at Penn State sheds light on how an enzyme that aids in the regulation of ageing and other metabolic processes accesses our genetic material to modify gene expression within the cell. A team led by Penn State researchers created images of a sirtuin enzyme bound to a nucleosome–a tightly packed complex of DNA and proteins called histones–showing how the enzyme navigates the nucleosome complex to access both DNA and histone proteins and clarifying how it functions in humans and other animals.
A study explaining the findings was published in the journal Science Advances on April 14th.
Sirtuins are a type of enzyme found in beings ranging from bacteria to humans that play critical roles in ageing, DNA damage detection, and tumour suppression in various malignancies. Pharmaceutical companies are investigating their potential for biomedical applications as a result of their diverse roles. Much attention has been paid to some sirtuins’ potential to reduce gene expression by removing a chemical flag from histone proteins.
“In our cells, DNA is not naked like we see it in textbooks; it is spooled around proteins called histones within a large complex called the nucleosome,” said Song Tan, Verne M. Willaman Professor of Molecular Biology at Penn State and an author of the paper. “This packaging can also contribute signals for turning on or turning off genes: Adding an ‘acetyl’ chemical flag to the histone packaging material turns on a gene while removing the acetyl flag turns the gene off. Sirtuins can silence gene activity by removing the acetyl flag from histones packaged into nucleosomes. Understanding how sirtuins interact with the nucleosome to remove this flag could inform future drug discovery efforts.”
Previous studies have focused on how sirtuins interact with short segments of histones in isolation, in part because such histone “tail” peptides are much easier to work with in the lab. According to Tan, the nucleosome is a hundred times larger than typical histone peptides used in these studies and is consequently much more complicated to work with.
“We have visualized a sirtuin enzyme called SIRT6 on its physiologically relevant substrate–the entire nucleosome,” said Jean-Paul Armache, assistant professor of biochemistry and molecular biology at Penn State and an author of the paper. “And we found that SIRT6 interacts with multiple parts of the nucleosome, not only the histone where the acetyl flag is to be modified”
Using a powerful type of imaging called cryo-electron microscopy with instruments at the Penn State Cryo-Electron Microscopy Facility, the National Cancer Institute and the Pacific Northwest Cryo-EM Center, the researchers identified how SIRT6 positions itself on the nucleosome in order to remove an acetyl group from the K9 position on the histone called H3. Following up with biochemical experiments–in collaboration with the lab of Craig Peterson at the University of Massachusetts Chan Medical School–helped confirm their results.
The researchers found that SIRT6 binds to the nucleosome using a type of connection called an “arginine anchor.” This type of binding–described by Tan’s lab in 2014–is used by a variety of proteins that target a particularly acidic patch on the nucleosome’s surface. In this case, a structural feature of SIRT6 called an extended loop nestles into a divot in the acidic patch, somewhat like a pipe sitting in a ditch.
“The arginine anchor is a common paradigm for how many chromatin proteins interact with the nucleosome,” said Tan. “When we mutated the SIRT6 arginine anchor, the activity at the K9 position was severely affected, supporting a critical role for the SIRT6’s arginine anchor. Surprisingly, this mutation also impacted SIRT6’s enzymatic activity at a different position, K56, located much further away.”
Instead of SIRT6 binding to the nucleosome in two different ways to access the two different histone positions, it is possible that SIRT6 binds to access K9 in a way that might also provide access to K56.
“SIRT6 binds to a partially unwrapped nucleosome, with DNA displaced from the end of the nucleosome” said Armache. “This exposes the K56 position, and it is possible that SIRT6 could essentially lean down to reach that position. We would like to validate this hypothesis in the future. We also hope to explore how SIRT6 works alongside other enzymes and to better understand its role in the response to DNA damage.”
This story has been published from a wire agency feed without modifications to the text. Only the headline has been changed.